HomeCompareBWV vs VIG

BWV vs VIG: Dividend Comparison 2026

BWV yields 1109.88% · VIG yields 1.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BWV wins by $47035737.26M in total portfolio value
10 years
BWV
BWV
● Live price
1109.88%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47035737.30M
Annual income
$39,954,235,177,691.26
Full BWV calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →

Portfolio growth — BWV vs VIG

📍 BWV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBWVVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BWV + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BWV pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BWV
Annual income on $10K today (after 15% tax)
$94,339.62/yr
After 10yr DRIP, annual income (after tax)
$33,961,099,901,037.57/yr
VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
At 15% tax rate, BWV beats the other by $33,961,099,900,885.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BWV + VIG for your $10,000?

BWV: 50%VIG: 50%
100% VIG50/50100% BWV
Portfolio after 10yr
$23517868.66M
Annual income
$19,977,117,588,935.21/yr
Blended yield
84.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BWV right now

BWV
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$4.00
+2119.8% upside vs current
Range: $4.00 — $4.00
Altman Z
-9.6
Piotroski
4/9
VIG
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BWV buys
0
VIG buys
0
No recent congressional trades found for BWV or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBWVVIG
Forward yield1109.88%1.64%
Annual dividend / share$2.00$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$47035737.30M$32.4K
Annual income after 10y$39,954,235,177,691.26$179.15
Total dividends collected$46502201.88M$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BWV vs VIG ($10,000, DRIP)

YearBWV PortfolioBWV Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$121,688$110,987.79$11,304$163.92+$110.4KBWV
2$1,392,436$1,262,229.83$12,759$166.33+$1.38MBWV
3$14,988,323$13,498,416.50$14,382$168.52+$14.97MBWV
4$151,830,358$135,792,852.99$16,192$170.52+$151.81MBWV
5$1,448,037,323$1,285,578,839.42$18,210$172.34+$1448.02MBWV
6$13,008,119,121$11,458,719,185.11$20,460$173.98+$13008.10MBWV
7$110,121,340,317$96,202,652,857.66$22,968$175.48+$110121.32MBWV
8$878,962,312,032$761,132,477,893.38$25,763$176.83+$878962.29MBWV
9$6,618,226,279,560$5,677,736,605,685.80$28,878$178.05+$6618226.25MBWV
10$47,035,737,296,821$39,954,235,177,691.26$32,350$179.15+$47035737.26MBWV

BWV vs VIG: Complete Analysis 2026

BWVStock

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

Full BWV Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this BWV vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BWV vs SCHDBWV vs JEPIBWV vs OBWV vs KOBWV vs MAINBWV vs DGROBWV vs NOBLBWV vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.